// <auto-generated/>
// Contents of: hl7.fhir.r3.core version: 3.0.2
// Minimum TypeScript Version: 3.7
// FHIR ValueSet: http://hl7.org/fhir/ValueSet/v3-ActSubstanceAdminSubstitutionCode|2014-03-26
/**
 * No Description Provided
 */
export const V3ActSubstanceAdminSubstitutionCodes = {
    /**
     * BC: Description:
     *
     *
     *                         Substitution occurred or is permitted between equivalent Brands but not Generics
     *
     *
     *                            Examples:
     *
     *
     *
     *                            Zestril  for Prinivil
     *                            Coumadin for Jantoven
     */
    BrandComposition: "BC",
    /**
     * E: Description: Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.
     */
    Equivalent: "E",
    /**
     * EC: Description:
     *
     *
     *                         Substitution occurred or is permitted with another product that is a:
     *
     *
     *                            pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester
     *                            pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration
     *
     *
     *                            Examples:
     *
     *
     *
     *
     *                               Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate
     *
     *                               Pharmaceutical equivalent: Lisonpril for Zestril
     */
    EquivalentComposition: "EC",
    /**
     * F: Description: This substitution was performed or is permitted based on formulary guidelines.
     */
    Formulary: "F",
    /**
     * G: Description: Substitution occurred or is permitted between equivalent Generics but not Brands
     *
     *
     *                            Examples:
     *
     *
     *
     *                            Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)
     */
    GenericComposition: "G",
    /**
     * N: No substitution occurred or is permitted.
     */
    None: "N",
    /**
     * TB: Description: Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics
     * &gt;
     *                            Examples:
     *
     *
     *
     *                            Zantac for Tagamet
     */
    TherapeuticBrand: "TB",
    /**
     * TE: Description: Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile.
     *
     *
     *                            Examples:
     *
     *
     *
     *                            ranitidine for Tagamet
     */
    TherapeuticAlternative: "TE",
    /**
     * TG: Description: Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands
     * &gt;
     *                            Examples:
     *
     *
     *
     *                            Ranitidine  for cimetidine
     */
    TherapeuticGeneric: "TG",
};
//# sourceMappingURL=data:application/json;base64,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